HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
about
Choices in medical management for prevention of acute ischemic strokeEvaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.Identification and management of difficult stroke and TIA syndromes.Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial.Treatment of lipid disorders after stroke.Medical therapy for secondary prevention of stroke.Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferationThe role of cholesterol and statins in Alzheimer's disease.The role of statins in preventing stroke.Evidence, education and practice.Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's diseaseSecondary stroke prevention: inside the vessels and beyond.Simvastatin: two decades in a circle.Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.New strategies for prevention of ischemic stroke: the LIFE study.Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.Statin use prior to ischemic stroke onset is associated with decreased in-hospital mortality.The differences of clinical parameters between small multiple ischemic lesions and single lesion detected by diffusion-weighted MRI.Atorvastatin enhances kainate-induced gamma oscillations in rat hippocampal slices.
P2860
Q28192558-5BC06B14-B5D5-4D22-A81B-9CF992F6CE54Q33187638-B38DF88F-B0B3-42EA-83C2-9C03EA554783Q33355932-CA9794D4-02E7-4193-BC6A-A004EAA694ADQ34187214-A2E170E4-D7C3-4FCC-88C9-6C3033015024Q34606331-98995588-2EA1-497A-ADD3-3B60E088C32FQ34674265-C18A270A-34E5-4002-9CF0-D8C6DF13FA71Q35008527-58C46585-CBED-48E6-B79D-727175BD95C8Q35036478-1B3A2B2B-2526-44CC-B555-C55C1553254DQ35550354-F7F69743-2305-4A20-9E47-B2AF1C176846Q35638053-787F0BD5-D98F-4C15-98E2-234A8C1F9461Q36110439-550273B9-B785-470C-8DBC-A5E51834A0C5Q36556403-70F11466-097C-4397-B453-EF3B9C8F6B49Q36584677-3242162E-8599-4C07-940B-C951D4AA27DFQ37056590-A457CEB2-E2D1-47E5-9A84-76FC489E692DQ37165690-D839E95A-E430-4DBD-A49E-943621D977DAQ37242931-7E09B1BA-5FB1-41BA-BC2E-4D45448450B9Q44010676-B1C06477-BAC4-4B9E-A7AA-6C6C0EDD71CAQ45301947-6261C560-8F9C-4B2D-A241-5B74F61ED467Q45903573-793AF911-5595-44D2-A69C-57C78B4A2125Q48577787-158D83E6-C61A-4CF4-8768-D44DACD94E83Q48659946-C6A74EC2-749C-4AC3-AEBB-C4FE4CFD1FBA
P2860
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@ast
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@en
type
label
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@ast
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@en
prefLabel
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@ast
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@en
P2093
P356
P1433
P1476
HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.
@en
P2093
P304
P356
10.1212/WNL.54.4.790
P407
P577
2000-02-01T00:00:00Z